Zumla, A;
Hui, DS;
Azhar, EI;
Memish, ZA;
Maeurer, M;
(2020)
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
[Letter].
Lancet
, 395
(10224)
E35-E36.
10.1016/S0140-6736(20)30305-6.
Preview |
Text
Zumla_1. Reducing mortality from 2019-nCoV -HDT must be an option.pdf - Accepted Version Download (606kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Reducing mortality from 2019-nCoV: host-directed therapies should be an option |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S0140-6736(20)30305-6 |
| Publisher version: | https://doi.org/10.1016/S0140-6736(20)30305-6 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10096886 |
Downloads since deposit
43Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
